XML 8 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Document and Entity Information - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Feb. 16, 2024
Jun. 30, 2023
Cover [Abstract]      
Document Type 10-K/A    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-39450    
Entity Registrant Name HARMONY BIOSCIENCES HOLDINGS, INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 82-2279923    
Entity Address, Postal Zip Code 19462    
Entity Address, Address Line One 630 W.    
Entity Address, Address Line Two Germantown Pike    
Entity Address, Address Line Three Suite 215    
Entity Address, City or Town Plymouth Meeting    
Entity Address, State or Province PA    
City Area Code 484    
Local Phone Number 539-9800    
Title of 12(b) Security Common Stock, par value $0.00001 value per share    
Trading Symbol HRMY    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction false    
Entity Shell Company false    
Entity Public Float     $ 1,174.5
Entity Common Stock, Shares Outstanding   56,769,081  
Entity Central Index Key 0001802665    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2023    
Amendment Flag true    
Amendment Description Harmony Biosciences Holdings, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment”) to its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, which was originally filed with the Securities and Exchange Commission (the “SEC”) on February 22, 2024 (the “Original Filing”). This Amendment is being filed to revise Part II “Item 9B. Other Information” by adding Rule 10b5-1 trading arrangements entered into or modified by certain of our officers during the quarter ended December 31, 2023.    
Auditor Name Deloitte & Touche LLP    
Auditor Firm ID 34    
Auditor Location Philadelphia, Pennsylvania